Because PSGL-1 is known to mediate immunoregulatory functions and to be expressed on multiple immune cell types, we aimed to study whether it has an immune-regulatory role on TAMs given that TAM markers, such as CD163 (12), correlate with PSGL-1 by mRNA expression across multiple tumor types in our analysis. The gene discussed is CD163; the disease is neoplasm.